LNC
ELV icon

Lincoln National Corp’s Elevance Health ELV Stock Holding History

Lincoln National Corp’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,866
Closed -$2M – 319
2024
Q1 		$2M Buy
3,866
+141
+4% +$70.1K 0.03% 326
2023
Q4 		$1.76M Buy
3,725
+492
+15% +$228K 0.03% 316
2023
Q3 		$1.41M Sell
3,233
-20
-0.6% -$9.07K 0.03% 323
2023
Q2 		$1.45M Buy
3,253
+756
+30% +$349K 0.03% 323
2023
Q1 		$1.15M Sell
2,497
-62
-2% -$29.5K 0.02% 350
2022
Q4 		$1.31M Buy
2,559
+156
+6% +$79.2K 0.03% 297
2022
Q3 		$1.09M Sell
2,403
-196
-8% -$93.8K 0.03% 321
2022
Q2 		$1.25M Sell
2,599
-38
-1% -$18.8K 0.03% 298
2022
Q1 		$1.29M Sell
2,637
-104
-4% -$47.5K 0.03% 303
2021
Q4 		$1.27M Buy
2,741
+270
+11% +$114K 0.03% 298
2021
Q3 		$921K Sell
2,471
-328
-12% -$125K 0.02% 354
2021
Q2 		$1.07M Sell
2,799
-301
-10% -$115K 0.02% 307
2021
Q1 		$1.11M Sell
3,100
-99
-3% -$31.8K 0.03% 271
2020
Q4 		$1.03M Buy
3,199
+38
+1% +$11.7K 0.03% 275
2020
Q3 		$849K Sell
3,161
-273
-8% -$73.5K 0.03% 285
2020
Q2 		$903K Buy
3,434
+75
+2% +$20K 0.03% 266
2020
Q1 		$763K Buy
3,359
+125
+4% +$34.1K 0.03% 260
2019
Q4 		$977K Buy
3,234
+1,210
+60% +$333K 0.03% 265
2019
Q3 		$486K Buy
2,024
+874
+76% +$239K 0.02% 352
2019
Q2 		$324K Buy
1,150
+300
+35% +$81.9K 0.01% 403
2019
Q1 		$244K Buy
+850
New +$246K 0.01% 438
2018
Q3 		– Sell
-923
Closed -$220K – 493
2018
Q2 		$220K Sell
923
-322
-26% -$74.6K 0.01% 430
2018
Q1 		$273K Sell
1,245
-218
-15% -$51.2K 0.01% 391
2017
Q4 		$329K Buy
+1,463
New +$312K 0.01% 466

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Lincoln National Corp's ELV Position: Q2 2024 in Review

Lincoln National Corp sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 3,866 shares — an estimated $2M sold.

Lincoln National Corp first reported a position in ELV in Q4 2017 and held it in 24 quarters. The position peaked at $2M in Q1 2024. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • Lincoln National Corp reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 3,866 Elevance Health shares in Q2 2024, an estimated $2M.
  • Lincoln National Corp first reported a position in Elevance Health in Q4 2017 and held it in 24 quarters.
  • Lincoln National Corp's Elevance Health position peaked at $2M in Q1 2024.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.